# pathway_0007: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0007.txt)

**Task:** `pathway`  
**Author key, unchanged:** **C** — Secondary metabolite biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MLSIDHVDWLELIRVTLHPLAKFPGPKLAGASYCYEFWYEVICGIQYTQKIIKLHEQYGPIVRINPDELHFNDVDFVDVVYTAGARKRDKSSHYLAGFGGVSKSTFGTLDHMHHRTRRRALNKFFSKSRVLQIEDSIHEKSQQLCDKFLAYRDQGPFDLTGAFSCIATDTVTEYCFGSSPGFLNQDGWEPNCKSYFETIERMAHVTRHVPWILYLAKWLPLSIIRLVSSDLNSFLVDTRVKKPERLKRVVLDAERHDAKDCPVFLELLNSDLPPREKSKQRFMYEANGATLAGSGSTAIAMSNIVYNLVANPRIGHKLRSELLGKVSDPKNLPRWSSLEELPYLTAVIHEGLRSMYDPSKERLPYDPSQERLPRIATEEELIYKDGSTPGKSKYVIPRGYAIGTSAHVVHSDESIFPNASQFNPERWLGRDGQRNRELERHLLSFSKGSRYCLGMHCRCTTCLALPASVRNGTRGY

[Multiple Choices]
A. dTTP biosynthesis. .
B. Membrane lipid metabolism. .
C. Secondary metabolite biosynthesis. .
D. L-leucine degradation
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for cytochrome P450 monooxygenase ppzE, annotated to secondary metabolite biosynthesis. The annotation cites a study on pyrrolopyrazine-producing biosynthetic gene clusters, supporting choice C, though this is database annotation rather than independently verified experimental evidence here.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is consistent with an enzyme, and its P450-like features could suggest oxidative metabolism, but P450s participate in many pathways. Those features do not distinguish secondary-metabolite biosynthesis from the listed alternatives.


**Missing item-specific fact**

> The protein-specific identity and functional association of ppzE with pyrrolopyrazine biosynthesis, which are absent from the supplied sequence and choices.


**Reason**

> Selecting C requires a protein-specific annotation or equivalent external functional evidence; generic sequence-based reasoning does not identify this pathway.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer evidence supports C for the exact sequence; no competing pathway annotation is provided.


### Important caveats

- Reviewer-only database evidence was not available to the evaluated model.
- The UniProt pathway annotation cites a publication, but the primary study was not independently assessed here.
- The author’s exact source snapshot is unknown, although the historical and current records both match the supplied sequence.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is consistent with an enzyme, and its P450-like features could suggest oxidative metabolism, but P450s participate in many pathways. Those features do not distinguish secondary-metabolite biosynthesis from the listed alternatives.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific identity and functional association of ppzE with pyrrolopyrazine biosynthesis, which are absent from the supplied sequence and choices.",
    "reason": "Selecting C requires a protein-specific annotation or equivalent external functional evidence; generic sequence-based reasoning does not identify this pathway."
  },
  "case_id": "pathway_0007",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for cytochrome P450 monooxygenase ppzE, annotated to secondary metabolite biosynthesis. The annotation cites a study on pyrrolopyrazine-producing biosynthetic gene clusters, supporting choice C, though this is database annotation rather than independently verified experimental evidence here."
  },
  "important_caveats": [
    "Reviewer-only database evidence was not available to the evaluated model.",
    "The UniProt pathway annotation cites a publication, but the primary study was not independently assessed here.",
    "The author’s exact source snapshot is unknown, although the historical and current records both match the supplied sequence."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports C for the exact sequence; no competing pathway annotation is provided."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0007",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for cytochrome P450 monooxygenase ppzE, annotated to secondary metabolite biosynthesis. The annotation cites a study on pyrrolopyrazine-producing biosynthetic gene clusters, supporting choice C, though this is database annotation rather than independently verified experimental evidence here.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is consistent with an enzyme, and its P450-like features could suggest oxidative metabolism, but P450s participate in many pathways. Those features do not distinguish secondary-metabolite biosynthesis from the listed alternatives.",
    "missing_item_specific_fact": "The protein-specific identity and functional association of ppzE with pyrrolopyrazine biosynthesis, which are absent from the supplied sequence and choices.",
    "reason": "Selecting C requires a protein-specific annotation or equivalent external functional evidence; generic sequence-based reasoning does not identify this pathway."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports C for the exact sequence; no competing pathway annotation is provided."
  },
  "important_caveats": [
    "Reviewer-only database evidence was not available to the evaluated model.",
    "The UniProt pathway annotation cites a publication, but the primary study was not independently assessed here.",
    "The author’s exact source snapshot is unknown, although the historical and current records both match the supplied sequence."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A455ZIK8 (PPZE_METMF) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (evidence C5, H3, ECO:0000305|PubMed:30452111). The protein is named 'Cytochrome P450 monooxygenase ppzE' / 'Pyrrolopyrazine biosynthesis cluster protein E' (C4, H1). Pyrrolopyrazines are fungal secondary metabolites, and the pathway assignment is supported by the primary literature (Berry et al. 2019, PubMed:30452111). The sequence matches exactly (476 aa, SHA256 confirmed).

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H1](#evidence-h1), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The C-terminal region contains the well-known P450 heme-binding signature 'FSKGSRYCLG' (evidence: 'FSKGSRYCLGMHCRCTTCLALPASVRNGTRGY'), which allows identification of the protein as a cytochrome P450 monooxygenase. This eliminates options A (dTTP biosynthesis – nucleotide metabolism, no P450s) and D (L-leucine degradation – amino acid catabolism, no P450s). However, P450 monooxygenases participate in both membrane lipid metabolism (option B; e.g., sterol hydroxylation, fatty acid ω-hydroxylation) and secondary metabolite biosynthesis (option C). Distinguishing between these two requires knowing that this specific P450 is ppzE, a pyrrolopyrazine biosynthetic gene cluster enzyme from Metarhizium majus, which is an item-specific database annotation not derivable from general sequence features alone.


**Missing item-specific fact**

> The identity of this P450 as ppzE, a member of the pyrrolopyrazine biosynthetic gene cluster in Metarhizium majus, and its specific assignment to secondary metabolite biosynthesis rather than primary lipid metabolism. No organism context, gene cluster context, or pathway annotation is provided in the model input.


**Reason**

> While the P450 family assignment is achievable from the conserved FSKGSRYCLG motif, the critical distinction between options B and C (both P450-mediated pathways) depends on knowing the specific protein identity and its biosynthetic gene cluster membership. The sequence alone does not provide organism context or gene cluster context that would allow a model to prefer secondary metabolite biosynthesis over membrane lipid metabolism without recalling or looking up the specific UniProt annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "C"
]
```

> Both membrane lipid metabolism (B) and secondary metabolite biosynthesis (C) commonly involve cytochrome P450 monooxygenases. Without organism context or gene cluster information, a model identifying only 'P450 monooxygenase' from the sequence could reasonably consider either pathway. The correct answer C is supported by the specific ppzE annotation, but option B is not eliminable from sequence motifs alone.


### Important caveats

- The UniProt pathway annotation uses evidence code ECO:0000305 (curator inference based on PubMed:30452111), not direct experimental measurement of the pathway in isolation; the primary paper characterized the BGC and assigned pathway context.
- The organism (Metarhizium majus, a fungus) is not provided in the model input, removing a key contextual clue that fungal P450s in BGCs are frequently secondary metabolite enzymes.
- The P450 heme-binding motif 'FSKGSRYCLG' is identifiable in the sequence, but P450 family assignment alone does not resolve the pathway sub-classification between B and C.
- The entry was first released in Swiss-Prot on 2025-02-05; the author's source snapshot date is unknown, though the sequence itself has been in databases since 2019.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The C-terminal region contains the well-known P450 heme-binding signature 'FSKGSRYCLG' (evidence: 'FSKGSRYCLGMHCRCTTCLALPASVRNGTRGY'), which allows identification of the protein as a cytochrome P450 monooxygenase. This eliminates options A (dTTP biosynthesis – nucleotide metabolism, no P450s) and D (L-leucine degradation – amino acid catabolism, no P450s). However, P450 monooxygenases participate in both membrane lipid metabolism (option B; e.g., sterol hydroxylation, fatty acid ω-hydroxylation) and secondary metabolite biosynthesis (option C). Distinguishing between these two requires knowing that this specific P450 is ppzE, a pyrrolopyrazine biosynthetic gene cluster enzyme from Metarhizium majus, which is an item-specific database annotation not derivable from general sequence features alone.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The identity of this P450 as ppzE, a member of the pyrrolopyrazine biosynthetic gene cluster in Metarhizium majus, and its specific assignment to secondary metabolite biosynthesis rather than primary lipid metabolism. No organism context, gene cluster context, or pathway annotation is provided in the model input.",
    "reason": "While the P450 family assignment is achievable from the conserved FSKGSRYCLG motif, the critical distinction between options B and C (both P450-mediated pathways) depends on knowing the specific protein identity and its biosynthetic gene cluster membership. The sequence alone does not provide organism context or gene cluster context that would allow a model to prefer secondary metabolite biosynthesis over membrane lipid metabolism without recalling or looking up the specific UniProt annotation."
  },
  "case_id": "pathway_0007",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H1",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A455ZIK8 (PPZE_METMF) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (evidence C5, H3, ECO:0000305|PubMed:30452111). The protein is named 'Cytochrome P450 monooxygenase ppzE' / 'Pyrrolopyrazine biosynthesis cluster protein E' (C4, H1). Pyrrolopyrazines are fungal secondary metabolites, and the pathway assignment is supported by the primary literature (Berry et al. 2019, PubMed:30452111). The sequence matches exactly (476 aa, SHA256 confirmed)."
  },
  "important_caveats": [
    "The UniProt pathway annotation uses evidence code ECO:0000305 (curator inference based on PubMed:30452111), not direct experimental measurement of the pathway in isolation; the primary paper characterized the BGC and assigned pathway context.",
    "The organism (Metarhizium majus, a fungus) is not provided in the model input, removing a key contextual clue that fungal P450s in BGCs are frequently secondary metabolite enzymes.",
    "The P450 heme-binding motif 'FSKGSRYCLG' is identifiable in the sequence, but P450 family assignment alone does not resolve the pathway sub-classification between B and C.",
    "The entry was first released in Swiss-Prot on 2025-02-05; the author's source snapshot date is unknown, though the sequence itself has been in databases since 2019."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "C"
    ],
    "reason": "Both membrane lipid metabolism (B) and secondary metabolite biosynthesis (C) commonly involve cytochrome P450 monooxygenases. Without organism context or gene cluster information, a model identifying only 'P450 monooxygenase' from the sequence could reasonably consider either pathway. The correct answer C is supported by the specific ppzE annotation, but option B is not eliminable from sequence motifs alone."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0007",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A455ZIK8 (PPZE_METMF) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (evidence C5, H3, ECO:0000305|PubMed:30452111). The protein is named 'Cytochrome P450 monooxygenase ppzE' / 'Pyrrolopyrazine biosynthesis cluster protein E' (C4, H1). Pyrrolopyrazines are fungal secondary metabolites, and the pathway assignment is supported by the primary literature (Berry et al. 2019, PubMed:30452111). The sequence matches exactly (476 aa, SHA256 confirmed).",
    "evidence_ids": ["C1", "C4", "C5", "H1", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The C-terminal region contains the well-known P450 heme-binding signature 'FSKGSRYCLG' (evidence: 'FSKGSRYCLGMHCRCTTCLALPASVRNGTRGY'), which allows identification of the protein as a cytochrome P450 monooxygenase. This eliminates options A (dTTP biosynthesis – nucleotide metabolism, no P450s) and D (L-leucine degradation – amino acid catabolism, no P450s). However, P450 monooxygenases participate in both membrane lipid metabolism (option B; e.g., sterol hydroxylation, fatty acid ω-hydroxylation) and secondary metabolite biosynthesis (option C). Distinguishing between these two requires knowing that this specific P450 is ppzE, a pyrrolopyrazine biosynthetic gene cluster enzyme from Metarhizium majus, which is an item-specific database annotation not derivable from general sequence features alone.",
    "missing_item_specific_fact": "The identity of this P450 as ppzE, a member of the pyrrolopyrazine biosynthetic gene cluster in Metarhizium majus, and its specific assignment to secondary metabolite biosynthesis rather than primary lipid metabolism. No organism context, gene cluster context, or pathway annotation is provided in the model input.",
    "reason": "While the P450 family assignment is achievable from the conserved FSKGSRYCLG motif, the critical distinction between options B and C (both P450-mediated pathways) depends on knowing the specific protein identity and its biosynthetic gene cluster membership. The sequence alone does not provide organism context or gene cluster context that would allow a model to prefer secondary metabolite biosynthesis over membrane lipid metabolism without recalling or looking up the specific UniProt annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "C"],
    "reason": "Both membrane lipid metabolism (B) and secondary metabolite biosynthesis (C) commonly involve cytochrome P450 monooxygenases. Without organism context or gene cluster information, a model identifying only 'P450 monooxygenase' from the sequence could reasonably consider either pathway. The correct answer C is supported by the specific ppzE annotation, but option B is not eliminable from sequence motifs alone."
  },
  "important_caveats": [
    "The UniProt pathway annotation uses evidence code ECO:0000305 (curator inference based on PubMed:30452111), not direct experimental measurement of the pathway in isolation; the primary paper characterized the BGC and assigned pathway context.",
    "The organism (Metarhizium majus, a fungus) is not provided in the model input, removing a key contextual clue that fungal P450s in BGCs are frequently secondary metabolite enzymes.",
    "The P450 heme-binding motif 'FSKGSRYCLG' is identifiable in the sequence, but P450 family assignment alone does not resolve the pathway sub-classification between B and C.",
    "The entry was first released in Swiss-Prot on 2025-02-05; the author's source snapshot date is unknown, though the sequence itself has been in databases since 2019."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record annotates the pathway as secondary metabolite biosynthesis and identifies the protein as a cytochrome P450 monooxygenase. The annotation cites a paper whose stated scope includes function and pathway, although the excerpts do not independently establish the experimental basis or strength of that evidence.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is consistent with a cytochrome P450 monooxygenase, including a C-terminal heme-thiolate cysteine region. P450s commonly catalyze oxidative tailoring steps in secondary-metabolite biosynthesis; that family-level pattern favors C over dTTP biosynthesis or L-leucine degradation, whose usual enzymes are different. The lack of an obvious N-terminal hydrophobic membrane anchor also makes a typical membrane-lipid P450 less compelling, though it does not rule out lipid metabolism.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> Transferable P450-family and sequence-feature knowledge provides a meaningful, probabilistic basis for C among the offered choices. The sequence alone does not prove the substrate or pathway, and P450s can participate in lipid metabolism, so this is not a definitive assignment.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> A lipid-metabolism role is biologically possible for a P450, but the sequence features and family-level pattern favor secondary-metabolite biosynthesis among these choices.


### Important caveats

- The reviewer-only database annotation applies to the exact supplied sequence, but its cited evidence was not independently examined here.
- The pathway inference from sequence is probabilistic; P450 family membership alone does not specify a substrate.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is consistent with a cytochrome P450 monooxygenase, including a C-terminal heme-thiolate cysteine region. P450s commonly catalyze oxidative tailoring steps in secondary-metabolite biosynthesis; that family-level pattern favors C over dTTP biosynthesis or L-leucine degradation, whose usual enzymes are different. The lack of an obvious N-terminal hydrophobic membrane anchor also makes a typical membrane-lipid P450 less compelling, though it does not rule out lipid metabolism.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "Transferable P450-family and sequence-feature knowledge provides a meaningful, probabilistic basis for C among the offered choices. The sequence alone does not prove the substrate or pathway, and P450s can participate in lipid metabolism, so this is not a definitive assignment."
  },
  "case_id": "pathway_0007",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates the pathway as secondary metabolite biosynthesis and identifies the protein as a cytochrome P450 monooxygenase. The annotation cites a paper whose stated scope includes function and pathway, although the excerpts do not independently establish the experimental basis or strength of that evidence."
  },
  "important_caveats": [
    "The reviewer-only database annotation applies to the exact supplied sequence, but its cited evidence was not independently examined here.",
    "The pathway inference from sequence is probabilistic; P450 family membership alone does not specify a substrate."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "A lipid-metabolism role is biologically possible for a P450, but the sequence features and family-level pattern favor secondary-metabolite biosynthesis among these choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0007",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates the pathway as secondary metabolite biosynthesis and identifies the protein as a cytochrome P450 monooxygenase. The annotation cites a paper whose stated scope includes function and pathway, although the excerpts do not independently establish the experimental basis or strength of that evidence.",
    "evidence_ids": ["C4", "C5", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is consistent with a cytochrome P450 monooxygenase, including a C-terminal heme-thiolate cysteine region. P450s commonly catalyze oxidative tailoring steps in secondary-metabolite biosynthesis; that family-level pattern favors C over dTTP biosynthesis or L-leucine degradation, whose usual enzymes are different. The lack of an obvious N-terminal hydrophobic membrane anchor also makes a typical membrane-lipid P450 less compelling, though it does not rule out lipid metabolism.",
    "missing_item_specific_fact": "",
    "reason": "Transferable P450-family and sequence-feature knowledge provides a meaningful, probabilistic basis for C among the offered choices. The sequence alone does not prove the substrate or pathway, and P450s can participate in lipid metabolism, so this is not a definitive assignment."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "A lipid-metabolism role is biologically possible for a P450, but the sequence features and family-level pattern favor secondary-metabolite biosynthesis among these choices."
  },
  "important_caveats": [
    "The reviewer-only database annotation applies to the exact supplied sequence, but its cited evidence was not independently examined here.",
    "The pathway inference from sequence is probabilistic; P450 family membership alone does not specify a substrate."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0A455ZIK8 explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (ECO:0000305|PubMed:30452111). The protein is a cytochrome P450 monooxygenase ppzE involved in pyrrolopyrazine biosynthesis, an alkaloid secondary metabolite pathway in the fungus Metarhizium majus. The evidence code ECO:0000305 indicates the pathway assignment is based on the primary literature (PubMed 30452111), not merely computational transfer. The sequence match is confirmed.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains recognizable cytochrome P450 hallmarks: the 'FGGVSKSTFGTLDHMHH' region in the mid-sequence corresponds to the conserved FxxGxxxCxG heme-binding motif region, and the C-terminal 'CLGMHCRCTTCLALPASVRNGTRGY' contains the axial cysteine ligand for heme iron. Recognition of these P450 features immediately eliminates A (dTTP biosynthesis: involves ribonucleotide reductase, thymidylate synthase, dihydrofolate reductase — no P450 involvement) and D (L-leucine degradation: involves branched-chain amino acid dehydrogenase, dihydrolipoamide acyltransferase, and dehydrogenases — no P450 involvement). Between B (membrane lipid metabolism) and C (secondary metabolite biosynthesis): P450s are overwhelmingly associated with secondary metabolite biosynthesis, particularly in fungi where they catalyze steps in alkaloid, terpenoid, and polyketide pathways within biosynthetic gene clusters. P450s in membrane lipid metabolism (e.g., fatty acid ω-hydroxylation) are comparatively rare and typically microsomal with distinct family signatures. The overall sequence architecture — a standard fungal-type P450 without obvious lipid-metabolism-specific adaptations — combined with the general statistical regularity that fungal P450 families are predominantly secondary-metabolism enzymes, provides a meaningful probabilistic preference for C over B.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model can recognize P450 sequence motifs (FGG region, C-terminal heme-binding cysteine), definitively eliminate A and D (no P450s in nucleotide or amino acid catabolic pathways), and use the well-established generalization that fungal P450s are predominantly secondary metabolite biosynthesis enzymes to favor C over B. This is a legitimate family-level and organismal-context inference learned from many other P450 proteins, not a lookup of this specific protein's annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> While P450s can theoretically participate in lipid metabolism (option B), this is a minority role compared to their overwhelming prevalence in secondary metabolite biosynthesis, especially in fungi. The P450 recognition cleanly eliminates A and D, and the general distribution of P450 functions across pathways provides a clear probabilistic preference for C over B. No other option is genuinely defensible.


### Important caveats

- The B-vs-C distinction relies on a probabilistic generalization about fungal P450 pathway distribution rather than a definitive structural or mechanistic proof. A P450 could in principle be in lipid metabolism, but this is statistically much less common in fungi.
- The fungal origin of the protein is not explicitly stated in the user input; the model must infer it from sequence composition or general P450 family knowledge. However, even without organism identification, the general P450-to-secondary-metabolism association across many organisms still favors C.
- The UniProt annotation (ECO:0000305) is based on a 2019 experimental paper characterizing the pyrrolopyrazine BGC, giving it stronger evidentiary weight than purely computational annotation.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains recognizable cytochrome P450 hallmarks: the 'FGGVSKSTFGTLDHMHH' region in the mid-sequence corresponds to the conserved FxxGxxxCxG heme-binding motif region, and the C-terminal 'CLGMHCRCTTCLALPASVRNGTRGY' contains the axial cysteine ligand for heme iron. Recognition of these P450 features immediately eliminates A (dTTP biosynthesis: involves ribonucleotide reductase, thymidylate synthase, dihydrofolate reductase — no P450 involvement) and D (L-leucine degradation: involves branched-chain amino acid dehydrogenase, dihydrolipoamide acyltransferase, and dehydrogenases — no P450 involvement). Between B (membrane lipid metabolism) and C (secondary metabolite biosynthesis): P450s are overwhelmingly associated with secondary metabolite biosynthesis, particularly in fungi where they catalyze steps in alkaloid, terpenoid, and polyketide pathways within biosynthetic gene clusters. P450s in membrane lipid metabolism (e.g., fatty acid ω-hydroxylation) are comparatively rare and typically microsomal with distinct family signatures. The overall sequence architecture — a standard fungal-type P450 without obvious lipid-metabolism-specific adaptations — combined with the general statistical regularity that fungal P450 families are predominantly secondary-metabolism enzymes, provides a meaningful probabilistic preference for C over B.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can recognize P450 sequence motifs (FGG region, C-terminal heme-binding cysteine), definitively eliminate A and D (no P450s in nucleotide or amino acid catabolic pathways), and use the well-established generalization that fungal P450s are predominantly secondary metabolite biosynthesis enzymes to favor C over B. This is a legitimate family-level and organismal-context inference learned from many other P450 proteins, not a lookup of this specific protein's annotation."
  },
  "case_id": "pathway_0007",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0A455ZIK8 explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (ECO:0000305|PubMed:30452111). The protein is a cytochrome P450 monooxygenase ppzE involved in pyrrolopyrazine biosynthesis, an alkaloid secondary metabolite pathway in the fungus Metarhizium majus. The evidence code ECO:0000305 indicates the pathway assignment is based on the primary literature (PubMed 30452111), not merely computational transfer. The sequence match is confirmed."
  },
  "important_caveats": [
    "The B-vs-C distinction relies on a probabilistic generalization about fungal P450 pathway distribution rather than a definitive structural or mechanistic proof. A P450 could in principle be in lipid metabolism, but this is statistically much less common in fungi.",
    "The fungal origin of the protein is not explicitly stated in the user input; the model must infer it from sequence composition or general P450 family knowledge. However, even without organism identification, the general P450-to-secondary-metabolism association across many organisms still favors C.",
    "The UniProt annotation (ECO:0000305) is based on a 2019 experimental paper characterizing the pyrrolopyrazine BGC, giving it stronger evidentiary weight than purely computational annotation."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While P450s can theoretically participate in lipid metabolism (option B), this is a minority role compared to their overwhelming prevalence in secondary metabolite biosynthesis, especially in fungi. The P450 recognition cleanly eliminates A and D, and the general distribution of P450 functions across pathways provides a clear probabilistic preference for C over B. No other option is genuinely defensible."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0007",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0A455ZIK8 explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (ECO:0000305|PubMed:30452111). The protein is a cytochrome P450 monooxygenase ppzE involved in pyrrolopyrazine biosynthesis, an alkaloid secondary metabolite pathway in the fungus Metarhizium majus. The evidence code ECO:0000305 indicates the pathway assignment is based on the primary literature (PubMed 30452111), not merely computational transfer. The sequence match is confirmed.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains recognizable cytochrome P450 hallmarks: the 'FGGVSKSTFGTLDHMHH' region in the mid-sequence corresponds to the conserved FxxGxxxCxG heme-binding motif region, and the C-terminal 'CLGMHCRCTTCLALPASVRNGTRGY' contains the axial cysteine ligand for heme iron. Recognition of these P450 features immediately eliminates A (dTTP biosynthesis: involves ribonucleotide reductase, thymidylate synthase, dihydrofolate reductase — no P450 involvement) and D (L-leucine degradation: involves branched-chain amino acid dehydrogenase, dihydrolipoamide acyltransferase, and dehydrogenases — no P450 involvement). Between B (membrane lipid metabolism) and C (secondary metabolite biosynthesis): P450s are overwhelmingly associated with secondary metabolite biosynthesis, particularly in fungi where they catalyze steps in alkaloid, terpenoid, and polyketide pathways within biosynthetic gene clusters. P450s in membrane lipid metabolism (e.g., fatty acid ω-hydroxylation) are comparatively rare and typically microsomal with distinct family signatures. The overall sequence architecture — a standard fungal-type P450 without obvious lipid-metabolism-specific adaptations — combined with the general statistical regularity that fungal P450 families are predominantly secondary-metabolism enzymes, provides a meaningful probabilistic preference for C over B.",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can recognize P450 sequence motifs (FGG region, C-terminal heme-binding cysteine), definitively eliminate A and D (no P450s in nucleotide or amino acid catabolic pathways), and use the well-established generalization that fungal P450s are predominantly secondary metabolite biosynthesis enzymes to favor C over B. This is a legitimate family-level and organismal-context inference learned from many other P450 proteins, not a lookup of this specific protein's annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While P450s can theoretically participate in lipid metabolism (option B), this is a minority role compared to their overwhelming prevalence in secondary metabolite biosynthesis, especially in fungi. The P450 recognition cleanly eliminates A and D, and the general distribution of P450 functions across pathways provides a clear probabilistic preference for C over B. No other option is genuinely defensible."
  },
  "important_caveats": [
    "The B-vs-C distinction relies on a probabilistic generalization about fungal P450 pathway distribution rather than a definitive structural or mechanistic proof. A P450 could in principle be in lipid metabolism, but this is statistically much less common in fungi.",
    "The fungal origin of the protein is not explicitly stated in the user input; the model must infer it from sequence composition or general P450 family knowledge. However, even without organism identification, the general P450-to-secondary-metabolism association across many organisms still favors C.",
    "The UniProt annotation (ECO:0000305) is based on a 2019 experimental paper characterizing the pyrrolopyrazine BGC, giving it stronger evidentiary weight than purely computational annotation."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A455ZIK8",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "1fcf124c6af1a1ae3c9cc65efd0c7e27b3e95d4c128b261f2675580e165f0de2",
  "benchmark_sequence_length": 476,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 24,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2019-06-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "c2a8aaa8bdb109947f9f5a47b1951c69aaf96c57998f03880669ff292a4051e7",
  "current_source_sequence_sha256": "1fcf124c6af1a1ae3c9cc65efd0c7e27b3e95d4c128b261f2675580e165f0de2",
  "current_source_sequence_length": 476,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 23,
  "selected_historical_version": {
    "accession": "A0A455ZIK8",
    "database": "Swiss-Prot",
    "entryVersion": 23,
    "firstRelease": "2025_01/2025_01",
    "firstReleaseDate": "05-Feb-2025",
    "lastRelease": "2026_02/2026_02",
    "lastReleaseDate": "10-Jun-2026",
    "name": "PPZE_METMF",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "d9a23aa96c9d27dcf6dee8b101909d437a113b00ab8996e2204980d630610008",
  "selected_historical_source_sequence_sha256": "1fcf124c6af1a1ae3c9cc65efd0c7e27b3e95d4c128b261f2675580e165f0de2",
  "selected_historical_source_sequence_length": 476,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 23,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZIK8.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZIK8.json",
  "source_sha256": "c2a8aaa8bdb109947f9f5a47b1951c69aaf96c57998f03880669ff292a4051e7",
  "retrieved_utc": "2026-11-02T04:25:12.579944+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A455ZIK8\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZIK8.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZIK8.json",
  "source_sha256": "c2a8aaa8bdb109947f9f5a47b1951c69aaf96c57998f03880669ff292a4051e7",
  "retrieved_utc": "2026-11-02T04:25:12.579944+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":24,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2019-06-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZIK8.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZIK8.json",
  "source_sha256": "c2a8aaa8bdb109947f9f5a47b1951c69aaf96c57998f03880669ff292a4051e7",
  "retrieved_utc": "2026-11-02T04:25:12.579944+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"DAC76721.1\",\"source\":\"EMBL\"}],\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Sordariomycetes\",\"Hypocreomycetidae\",\"Hypocreales\",\"Clavicipitaceae\",\"Metarhizium\",\"Metarhizium majus\"],\"scientificName\":\"Metarhizium majus (strain ARSEF 297)\",\"taxonId\":1276143}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZIK8.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZIK8.json",
  "source_sha256": "c2a8aaa8bdb109947f9f5a47b1951c69aaf96c57998f03880669ff292a4051e7",
  "retrieved_utc": "2026-11-02T04:25:12.579944+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"30452111\",\"source\":\"PubMed\"}],\"value\":\"Pyrrolopyrazine biosynthesis cluster protein E\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"30452111\",\"source\":\"PubMed\"}],\"value\":\"1.-.-.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"30452111\",\"source\":\"PubMed\"}],\"value\":\"Cytochrome P450 monooxygenase ppzE\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZIK8.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZIK8.json",
  "source_sha256": "c2a8aaa8bdb109947f9f5a47b1951c69aaf96c57998f03880669ff292a4051e7",
  "retrieved_utc": "2026-11-02T04:25:12.579944+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"30452111\",\"source\":\"PubMed\"}],\"value\":\"Secondary metabolite biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZIK8.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZIK8.json",
  "source_sha256": "c2a8aaa8bdb109947f9f5a47b1951c69aaf96c57998f03880669ff292a4051e7",
  "retrieved_utc": "2026-11-02T04:25:12.579944+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Berry D.\",\"Mace W.\",\"Rehner S.A.\",\"Grage K.\",\"Dijkwel P.P.\",\"Young C.A.\",\"Scott B.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"30452111\"},{\"database\":\"DOI\",\"id\":\"10.1111/1462-2920.14483\"}],\"citationType\":\"journal article\",\"firstPage\":\"928\",\"id\":\"30452111\",\"journal\":\"Environ. Microbiol.\",\"lastPage\":\"939\",\"publicationDate\":\"2019\",\"title\":\"Orthologous peramine and pyrrolopyrazine-producing biosynthetic gene clusters in Metarhizium rileyi, Metarhizium majus and Cladonia grayi.\",\"volume\":\"21\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"ARSEF 297\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A455ZIK8?format=txt&versions=23)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A455ZIK8?format=txt&versions=23",
  "source_sha256": "d9a23aa96c9d27dcf6dee8b101909d437a113b00ab8996e2204980d630610008",
  "retrieved_utc": "2026-11-02T04:25:16.735081+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   PPZE_METMF              Reviewed;         476 AA.\nAC   A0A455ZIK8;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-JUN-2019, sequence version 1.\nDT   05-FEB-2025, entry version 23.\nDE   RecName: Full=Cytochrome P450 monooxygenase ppzE {ECO:0000303|PubMed:30452111};\nDE            EC=1.-.-.- {ECO:0000305|PubMed:30452111};\nDE   AltName: Full=Pyrrolopyrazine biosynthesis cluster protein E {ECO:0000303|PubMed:30452111};\nGN   Name=ppzE {ECO:0000303|PubMed:30452111};\nOS   Metarhizium majus (strain ARSEF 297).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;\nOC   Hypocreomycetidae; Hypocreales; Clavicipitaceae; Metarhizium;\nOC   Metarhizium majus.\nOX   NCBI_TaxID=1276143 {ECO:0000312|EMBL:DAC76721.1};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 23,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A455ZIK8?format=txt&versions=23)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A455ZIK8?format=txt&versions=23",
  "source_sha256": "d9a23aa96c9d27dcf6dee8b101909d437a113b00ab8996e2204980d630610008",
  "retrieved_utc": "2026-11-02T04:25:16.735081+00:00",
  "source_locator": "lines 15-23",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRC   STRAIN=ARSEF 297;\nRX   PubMed=30452111; DOI=10.1111/1462-2920.14483;\nRA   Berry D., Mace W., Rehner S.A., Grage K., Dijkwel P.P., Young C.A.,\nRA   Scott B.;\nRT   \"Orthologous peramine and pyrrolopyrazine-producing biosynthetic gene\nRT   clusters in Metarhizium rileyi, Metarhizium majus and Cladonia grayi.\";\nRL   Environ. Microbiol. 21:928-939(2019).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 23,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A455ZIK8?format=txt&versions=23)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A455ZIK8?format=txt&versions=23",
  "source_sha256": "d9a23aa96c9d27dcf6dee8b101909d437a113b00ab8996e2204980d630610008",
  "retrieved_utc": "2026-11-02T04:25:16.735081+00:00",
  "source_locator": "lines 53-54",
  "excerpt": "CC   -!- PATHWAY: Secondary metabolite biosynthesis.\nCC       {ECO:0000305|PubMed:30452111}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 23,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 7. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
